Search results for "From ACP Hospitalist"
Two-step testing for Clostridioides difficile appears safe in multicenter study
Using an enzyme immunoassay after a positive nucleic acid amplification test was associated with a decrease in hospital-onset Clostridioides difficile infections and a reduction in related antibiotic use but no change in emergent colectomies.
https://gastroenterology.acponline.org/archives/2023/06/23/7.htm
23 Jun 2023
Patients with discordant C. difficile test results had lower mortality with treatment
Patients who were positive for Clostridioides difficile on nucleic acid amplification testing but negative on toxin immunoassay had similar 30-day mortality to those with positive results on both tests, according to a review of observational studies.
https://gastroenterology.acponline.org/archives/2023/09/22/7.htm
22 Sep 2023
Catching C. diff cases, not colonization
Researchers have found innovative ways to improve hospital systems for diagnosing Clostridioides difficile.
https://gastroenterology.acponline.org/archives/2023/08/25/8.htm
25 Aug 2023
A click to improve cirrhosis care
An electronic alert increased use of rifaximin in patients with cirrhosis who were taking lactulose and were admitted with hepatic encephalopathy.
https://gastroenterology.acponline.org/archives/2022/06/24/7.htm
24 Jun 2022
Two risk scores most accurately predict outcomes after lower GI bleeding
The Oakland score performed best for predicting safe discharge, major bleeding, and transfusion, while the Strate score performed best for hemostasis, according to a recent review and meta-analysis that assessed four scores.
https://gastroenterology.acponline.org/archives/2022/06/24/6.htm
24 Jun 2022
Surgery for malignant small bowel obstruction did not reduce 90-day mortality
A comparison in which some patients with malignant small bowel obstruction were randomized and some chose between surgery and nonsurgical management found no difference in mortality between treatments, but surgery was associated with more symptom improvement.
https://gastroenterology.acponline.org/archives/2023/08/25/9.htm
25 Aug 2023
C. diff recurrence risk reduced with bezlotoxumab versus placebo, industry study finds
The number needed to treat to prevent one Clostridium difficile recurrence was 10 in the overall patient population and 6 in patients age 65 years and over and those with previous infections.
https://gastroenterology.acponline.org/archives/2017/02/24/6.htm
24 Feb 2017
Recent conference coverage featured gastroenterology and hepatology topics
Conference coverage in the December ACP Hospitalist addressed acute-on-chronic liver failure and inpatient constipation.
https://gastroenterology.acponline.org/archives/2018/12/28/8.htm
28 Dec 2018
Stopping the cycle of C. diff
Microbiota therapies offer exciting potential to reduce the burden of recurrent Clostridioides difficile infection, experts say.
https://gastroenterology.acponline.org/archives/2023/02/24/8.htm
24 Feb 2023
Short course of antibiotics worked as well as long for Enterobacteriaceae bacteremia
Rates of mortality, recurrent bloodstream infections, and Clostridium difficile infections within 30 days were similar whether patients received eight or 15 days of antibiotics.
https://gastroenterology.acponline.org/archives/2017/10/27/9.htm
27 Oct 2017